Proposed Data Collections Submitted for Public Comment and Recommendations, 11983-11984 [05-4683]
Download as PDF
11983
Federal Register / Vol. 70, No. 46 / Thursday, March 10, 2005 / Notices
while traveling on a conveyance.
Additional burden hours for the
voluntary reporting of additional certain
illnesses and the Passenger Locator
Form are reflected in the burden hour
table below.
DHHS delegates authority to CDC to
conduct quarantine control measures.
Currently, with the exception of rodent
inspections and the cruise ship
sanitation program, inspections are
performed only on those vessels and
aircraft which report illness prior to
arrival or when illness is discovered
upon arrival. Other inspection agencies
assist quarantine officers in public
health screening of persons, pets, and
other importations of public health
significance and make referrals to PHS
when indicated. These practices and
procedures assure protection against the
introduction and spread of
communicable diseases into the United
States with a minimum of
Radio reporting of death/illness .......................................................................
Report by persons held in isolation/Surveillance ............................................
Report of death or Illness on carrier during stay in port .................................
Passenger locator form:
—Used in an outbreak of public health significance ................................
—Used for reportingof an ill passengers ..................................................
Requirements for admission of dogs and cats:
Sec. 72.51(1) ............................................................................................
Sec. 72.51(2) ............................................................................................
Application for permits to import turtles ...........................................................
Requirements for registered importers of nonhuman primates:
Sec. 71.53(1) ............................................................................................
Sec. 71.53(2) ............................................................................................
Total ...................................................................................................
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0494]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5973 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
VerDate jul<14>2003
18:28 Mar 09, 2005
Jkt 205001
Average burden per response
(in hrs.)
Number of respondents
Respondents
Dated: February 25, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–4679 Filed 3–9–05; 8:45 am]
recordkeeping and reporting as well as
a minimum of interference with trade
and travel.
Respondents include airplane pilots,
ships’ captains, importers, and travelers.
The nature of the quarantine response
would dictate which forms are
completed by whom. There is no cost to
respondents except for their time.
Annualized Burden Table:
Number of responses per
respondent
1700
11
5
1
1
1
2/60
30/60
30/60
57
6
2.50
2,700,000
800
1
1
5/60
5/60
225,000
67
5
1,200
10
1
1
1
3/60
15/60
30/60
.25
300
5
........................
........................
........................
1
4
........................
10/60
30/60
........................
7
60
225,505
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Exposure to Aerosolized Brevetoxins
during Red Tide Events (OMB No.
0920–0494)—Revision—National Center
for Environmental Health (NCEH),
Centers for Disease Control and
Prevention (CDC).
Karenia brevis (formerly
Gymnodinium breve) is the marine
dinoflagellate responsible for extensive
blooms (called red tides) that form in
the Gulf of Mexico. K. brevis produces
potent toxins, called brevetoxins, that
have been responsible for killing
millions of fish and other marine
organisms. The biochemical activity of
brevetoxins is not completely
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Total burden
hours
understood and there is very little
information regarding human health
effects from environmental exposures,
such as inhaling brevetoxin that has
been aerosolized and swept onto the
coast by offshore winds. The National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC) has recruited people
who work along the coast of Florida and
who are periodically occupationally
exposed to aerosolized red tide toxins.
We have administered a base-line
respiratory health questionnaire and
conducted pre- and post-shift
pulmonary function tests during a time
when there is no red tide reported near
the area. When a red tide developed, we
administered a symptom survey and
conducted pulmonary function testing
(PFT). We compared (1) symptom
reports before and during the red tide
and (2) the changes in baseline PFT
values during the work shift (differences
between pre- and post-shift PFT results)
without exposure to red tide with the
changes in PFT values during the work
shift when individuals are exposed to
red tide.
Unfortunately, the exposures
experienced by our study cohort have
been minimal, and we plan to conduct
another study (using the same symptom
questionnaires and spirometry tests)
during a more severe red tide event.
E:\FR\FM\10MRN1.SGM
10MRN1
11984
Federal Register / Vol. 70, No. 46 / Thursday, March 10, 2005 / Notices
In addition, we are now planning to
quantify the levels of cytokines in nasal
exudates to assess whether they can be
used to verify exposure and to
demonstrate a biological effect (i.e.,
allergic response) following inhalation
of aerosolized brevetoxins. We plan to
include not only the study subjects who
have been involved in our earlier
studies, but also any new individuals
who are hired to work at the relevant
beaches. As mentioned above, we have
collected part data on occupational
exposure to red tides. However, because
we are dealing with natural phenomena
and are subject literally to the tides, and
because the scientific questions are
evolving as we learn more, we must
extend our data collection time for an
additional three years. There are no
costs to respondents except for their
time.
Annualized Burden Table:
Number of
responses per
respondent
Number of
respondents
Respondents
Average
burden per response
Total burden
Pulmonary History Questionnaire ....................................................................
Spirometry ........................................................................................................
Nasal exudates collection/Nasal wash ............................................................
Symptom Questionnaire ..................................................................................
Hearing test .....................................................................................................
Beach Survey ..................................................................................................
5
25
25
25
25
5
1
6
6
6
6
160
20/60
20/60
10/60
5/60
15/60
5/60
2
50
25
13
38
67
Total ..........................................................................................................
........................
........................
........................
195
Dated: March 3, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–4683 Filed 3–9–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–05–04KE]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 371–5976 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC via fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Evaluation of the Sexually
Transmitted Disease (STD) Faculty
Expansion Program (FEP)—New—
National Center for HIV, STD, and TB
Prevention (NCHSTP), Centers for
Disease Control and Prevention (CDC).
Background:
Primary care physicians play a
significant role in STD prevention and
VerDate jul<14>2003
18:28 Mar 09, 2005
Jkt 205001
control. Diagnosing, treating, reporting,
partner notification, and patient
counseling which emphasizes
appropriate prevention messages, are all
important physician contributions to
STD control. In the curricula of most
medical schools and residency
programs, STDs and the public health
role of primary care physicians in their
control and prevention receive little
emphasis.
To address this lack of training, CDC
implemented the STD Faculty
Expansion Program (FEP), which aims
to improve capacity of primary care
physicians to diagnose, treat, and
prevent STDs. The FEP provides
medical schools with funding for an
additional faculty member to develop
and implement curriculum for training
medical students and residents, develop
collaborative relationships with local
health departments, and coordinate STD
clinical experiences for medical
students and residents. The potential
long-tern impact of the STD-related
training includes: Increase physician
awareness of STDs, greater comfort and
confidence in counseling patients,
increased case reporting and partner
management, and ultimately lower STD
incidence.
This project is an evaluation of the
FEP. Because the outcomes of greatest
relevance (increased physician
awareness, increased collaboration with
public health departments, decreased
STD incidence) will occur only after
students and residents who are
currently receiving the enhanced
training go into practice, the evaluation
focuses on intermediate outcomes as a
means of assessing the program’s utility
and effectiveness.
Four medical schools (e.g. Morehouse
School of Medicine, University of
Alabama at Birmingham, Louisiana
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
State University Medical Center, and the
University of California Los Angeles
School of Medicine) currently receive
support under the FEP. The evaluation
of the FEP consists of a survey of thirdyear medical students at the four
currently funded schools and a sample
of third-year medical students in all
other U.S. medical schools.
A paper-and-pencil survey instrument
will be administered to the students in
the four FEP schools in a classroom or
clinic setting or through the school mail
distribution system. The survey
instrument will be distributed to the
sample of students from all other
medical schools using express mail.
Survey topics will include:
—Hours of clinical and didactic training
received during the first three years of
medical school.
—Knowledge and efficacy with basic
STD clinical diagnosis, treatment, and
prevention.
—Students’ confidence in taking a
sexual history and providing specific
prevention counseling to patients.
—Student familiarity with the role of
the public health department in
control and prevention of STDs.
A total of 850 students will be
surveyed—approximately 425 at the
FEP schools and 425 from all other U.S.
medical schools. Evidence that the
FEP’s enhanced STD training is effective
will include greater knowledge of and
comfort in diagnosis, treatment and
prevention of STDs among FEP
students, recall of more time having
been devoted to STDs during medical
training, and greater awareness of the
primary care physician’s public health
role in STD control and prevention. The
time required to complete the survey
will be approximately 25 minutes. The
total annual burden for this data
collection is 354 hours.
E:\FR\FM\10MRN1.SGM
10MRN1
Agencies
[Federal Register Volume 70, Number 46 (Thursday, March 10, 2005)]
[Notices]
[Pages 11983-11984]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4683]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-0494]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5973 or
send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Exposure to Aerosolized Brevetoxins during Red Tide Events (OMB No.
0920-0494)--Revision--National Center for Environmental Health (NCEH),
Centers for Disease Control and Prevention (CDC).
Karenia brevis (formerly Gymnodinium breve) is the marine
dinoflagellate responsible for extensive blooms (called red tides) that
form in the Gulf of Mexico. K. brevis produces potent toxins, called
brevetoxins, that have been responsible for killing millions of fish
and other marine organisms. The biochemical activity of brevetoxins is
not completely understood and there is very little information
regarding human health effects from environmental exposures, such as
inhaling brevetoxin that has been aerosolized and swept onto the coast
by offshore winds. The National Center for Environmental Health (NCEH),
Centers for Disease Control and Prevention (CDC) has recruited people
who work along the coast of Florida and who are periodically
occupationally exposed to aerosolized red tide toxins.
We have administered a base-line respiratory health questionnaire
and conducted pre- and post-shift pulmonary function tests during a
time when there is no red tide reported near the area. When a red tide
developed, we administered a symptom survey and conducted pulmonary
function testing (PFT). We compared (1) symptom reports before and
during the red tide and (2) the changes in baseline PFT values during
the work shift (differences between pre- and post-shift PFT results)
without exposure to red tide with the changes in PFT values during the
work shift when individuals are exposed to red tide.
Unfortunately, the exposures experienced by our study cohort have
been minimal, and we plan to conduct another study (using the same
symptom questionnaires and spirometry tests) during a more severe red
tide event.
[[Page 11984]]
In addition, we are now planning to quantify the levels of
cytokines in nasal exudates to assess whether they can be used to
verify exposure and to demonstrate a biological effect (i.e., allergic
response) following inhalation of aerosolized brevetoxins. We plan to
include not only the study subjects who have been involved in our
earlier studies, but also any new individuals who are hired to work at
the relevant beaches. As mentioned above, we have collected part data
on occupational exposure to red tides. However, because we are dealing
with natural phenomena and are subject literally to the tides, and
because the scientific questions are evolving as we learn more, we must
extend our data collection time for an additional three years. There
are no costs to respondents except for their time.
Annualized Burden Table:
----------------------------------------------------------------------------------------------------------------
Number of Average
Respondents Number of responses per burden per Total burden
respondents respondent response
--------------------------------------------------------------------------------------------------
Pulmonary History Questionnaire... 5 1 20/60 2
Spirometry........................ 25 6 20/60 50
Nasal exudates collection/Nasal 25 6 10/60 25
wash.............................
Symptom Questionnaire............. 25 6 5/60 13
Hearing test...................... 25 6 15/60 38
Beach Survey...................... 5 160 5/60 67
-----------------
Total......................... .............. .............. .............. 195
----------------------------------------------------------------------------------------------------------------
Dated: March 3, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. 05-4683 Filed 3-9-05; 8:45 am]
BILLING CODE 4163-18-P